Association between phage types and antimicrobial resistance among bovine Staphylococcus aureus from 10 countries.
This study was conducted to investigate the diversity of phage types and associations between penicillin resistance and phage types among 815 Staphylococcus aureus isolates from bovine mastitis in nine European countries and USA. All isolates were examined for susceptibility to antimicrobial agents and characterised by phage typing. Penicillin resistance was found among strains from all countries with an average occurrence of 32.4% (2-71.4%). A total of 76% of isolates were identifiable by phage typing and 144 different phage types were observed. The most predominant types were phage type 29 (11% of the 815 isolates), phage type 52 (5%), and phage type 80 (5%). Phage type 95 and 29/52/52A/80 were both distributed within seven countries. In the countries with the highest occurrence of penicillin resistance a reduced diversity of phage types and phage groups was observed. Phage group III was significantly associated with penicillin resistance in contrast to phage group I (P=0.0023) and phage complex-80 (P=0.0066). This study confirms that a large number of phage types of S. aureus cause bovine mastitis, but that some types predominate. In addition, these findings could indicate that the use of penicillin in the bovine environment has selected for specific types of S. aureus in countries with a high frequency of resistance.
Vintov
Jan
J
Danish Veterinary Institute, Bülowsvej 27, DK-1790, Copenhagen, Denmark.
Aarestrup
Frank Møller
FM
Zinn
Christina Elsberg
CE
Olsen
John Elmerdahl
JE
D000818:Animals; D001434:Bacteriophage Typing / Q000662:veterinary; D002417:Cattle; D005060:Europe; D005260:Female; D014644:Genetic Variation / Q000235:genetics; D016015:Logistic Models; D008414:Mastitis, Bovine / Q000188:drug therapy / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D010403:Penicillin Resistance / Q000235:genetics; D010406:Penicillins / Q000494:pharmacology* / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*; D013211:Staphylococcus aureus / Q000145:classification* / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D014481:United States; D001618:beta-Lactamases / Q000378:metabolism
D010406:Penicillins; D001618:beta-Lactamases